Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms

GH Oliveira-Paula, R Lacchini, JE Tanus-Santos - Gene, 2016 - Elsevier
Nitric oxide (NO) is an important vasodilator with a well-established role in cardiovascular
homeostasis. While mediator is synthesized from L-arginine by neuronal, endothelial, and …

Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and ischemic stroke: meta-analysis

LK Wei, A Au, S Menon, LR Griffiths, CW Kooi… - Journal of Stroke and …, 2017 - Elsevier
Introduction The association between ischemic stroke and genetic polymorphisms of
methylenetetrahydrofolate reductase (MTHFR; 677C> T and 1298A> C), endothelial nitric …

[HTML][HTML] Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases

GH Oliveira-Paula, R Lacchini, JE Tanus-Santos - Nitric Oxide, 2017 - Elsevier
Nitric oxide (NO) is a vasoactive substance synthesized from l-arginine by neuronal (NOS1),
endothelial (NOS3), and inducible (NOS2) nitric oxide synthases. NOS3 is the most …

Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells

TC Izidoro-Toledo, DA Guimaraes, VA Belo… - Naunyn-Schmiedeberg's …, 2011 - Springer
Statins exert anti-inflammatory effects and downregulate matrix metalloproteinases (MMPs)
expression, thus contributing to restore cardiovascular homeostasis in cardiovascular …

eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril

PS Silva, V Fontana, MR Luizon, R Lacchini… - European journal of …, 2013 - Springer
Purpose The antihypertensive effect of angiotensin-converting enzyme inhibitors (ACEi) is
attributed partially to increased nitric oxide bioavailability. It is possible that functional …

Relationship between Arginase 1 and Arginase 2 levels and genetic polymorphisms with erectile dysfunction

R Lacchini, JJ Muniz, YTDA Nobre, AJ Cologna… - Nitric Oxide, 2015 - Elsevier
Arginase 1 and Arginase 2 are homologous enzymes that convert l-Arginine to Urea and l-
ornithine and compete with nitric oxide synthases for l-Arginine. Increased Arginase 1 and 2 …

Clinically relevant endothelial nitric oxide synthase polymorphisms and their impact on drug response

CK Cotta Filho, GH Oliveira-Paula… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Nitric oxide (NO) is a molecule with multiple functions. Several drugs involve the
modulation of NO levels in their mechanism of action. NO is mainly produced in vessels by …

eNOS polymorphism associated with metabolic syndrome in children and adolescents

JA Miranda, VA Belo, DC Souza-Costa… - Molecular and cellular …, 2013 - Springer
We investigated whether genetic polymorphisms in the endothelial nitric oxide (eNOS) gene
(T 786 C in the promoter region, Glu298Asp in exon 7, and 4b/4a in intron 4) or eNOS …

Pharmacogenetic implications of eNOS polymorphisms (Glu298Asp, T786C, 4b/4a) in cardiovascular drug therapy

A Cozma, A Fodor, OH Orasan, R Vulturar… - in vivo, 2019 - iv.iiarjournals.org
Endothelial nitric oxide synthase (NOS3 or eNOS) is the enzyme responsible for the highest
production of nitric oxide, with the greatest impact on the cardiovascular system, encoded by …

Pharmacogenetic relevance of endothelial nitric oxide synthase polymorphisms and gene interactions

MR Luizon, DA Pereira, JE Tanus-Santos - Pharmacogenomics, 2018 - Taylor & Francis
Endothelial nitric oxide synthase (NOS3) is a key enzyme responsible for nitric oxide (NO)
generation in the vascular endothelium. Endothelial dysfunction is characterized by reduced …